Home / Late quarterly reports / ULIXE CORP.

4/5ULIXE CORP. (WRPT): Late quarterly report (NT 10-Q)

Filed 2025-06-17 路 Form NT 10-Q 路 Accession 0001139020-25-000176 nano

Market data

Price before filing: $0.075 (2025-06-16 close, split/dividend-adjusted)
Market cap at flag: $10.5M (2025-06-17) 路 Latest: $16.0M (2025-12-26)

What happened next

WindowWRPTSPYvs SPY
30 days-3.9%+4.5%-8.4%2025-07-17
90 days-31.9%+10.0%-41.9%2025-09-15
180 days+6.7%+13.6%-6.9%2025-12-15

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Insider trading around this filing

90 days before the flag: no open-market insider sales or purchases reported.
30 days after: none reported.

Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-03-19 to 2025-07-17. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.

What this means

The company told the SEC it could not file its quarterly report on time (Form NT 10-Q) and then missed the 5-day extension too. Repeated late filings are a stronger warning.

Status: filed late (report filed 2025-06-23)

Why this score: filed late on 2025-06-23; also within 90 days: Going-concern doubt

Read the original filing on SEC.gov →

Not investment advice. Automated summary; verify against the filing.

Get the weekly "Red Flags" newsletter

The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.

Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.

Form not showing? Subscribe on beehiiv →

Newsletter delivered by beehiiv. See our privacy policy.